WO2002068457A3 - Antiangiogenic peptides derived from endostatin - Google Patents
Antiangiogenic peptides derived from endostatin Download PDFInfo
- Publication number
- WO2002068457A3 WO2002068457A3 PCT/IT2002/000119 IT0200119W WO02068457A3 WO 2002068457 A3 WO2002068457 A3 WO 2002068457A3 IT 0200119 W IT0200119 W IT 0200119W WO 02068457 A3 WO02068457 A3 WO 02068457A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- endostatin
- peptides derived
- antiangiogenic peptides
- antiangiogenic
- peptides
- Prior art date
Links
- 230000001772 anti-angiogenic effect Effects 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 102400001047 Endostatin Human genes 0.000 title 1
- 108010079505 Endostatins Proteins 0.000 title 1
- 101500026378 Homo sapiens Endostatin Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002241253A AU2002241253A1 (en) | 2001-02-27 | 2002-02-27 | Antiangiogenic peptides derived from endostatin |
US10/468,759 US20040073007A1 (en) | 2001-02-27 | 2002-02-27 | Antiangiogenic peptides |
EP20020707102 EP1370587A2 (en) | 2001-02-27 | 2002-02-27 | Antiangiogenic peptides derived from endostatin |
JP2002567967A JP2004534736A (en) | 2001-02-27 | 2002-02-27 | Anti-angiogenic peptide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000394A ITMI20010394A1 (en) | 2001-02-27 | 2001-02-27 | PEPTIDES WITH ANTIANGIOGENIC ACTIVITY |
ITMI2001A000394 | 2001-02-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002068457A2 WO2002068457A2 (en) | 2002-09-06 |
WO2002068457A3 true WO2002068457A3 (en) | 2002-11-14 |
Family
ID=11447030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT2002/000119 WO2002068457A2 (en) | 2001-02-27 | 2002-02-27 | Antiangiogenic peptides derived from endostatin |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040073007A1 (en) |
EP (1) | EP1370587A2 (en) |
JP (1) | JP2004534736A (en) |
AU (1) | AU2002241253A1 (en) |
IT (1) | ITMI20010394A1 (en) |
WO (1) | WO2002068457A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007529410A (en) * | 2003-08-29 | 2007-10-25 | チルドレンズ メディカル センター コーポレーション | Peptides for treating or preventing endometriosis |
US7524811B2 (en) * | 2003-08-29 | 2009-04-28 | Children's Medical Center Corporation | Anti-angiogenic peptides from the N-terminus of endostatin |
ITMI20040364A1 (en) * | 2004-02-27 | 2004-05-27 | Francesco Chillemi | PEPTIDES WITH ANTIANGIOGENIC AND ANTI-TUMOR ACTIVITY |
EP1640382A1 (en) * | 2004-08-16 | 2006-03-29 | Université de Liège | Anti-angiogenic peptides |
WO2011050311A1 (en) | 2009-10-22 | 2011-04-28 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Use of endostatin peptides for the treatment of fibrosis |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015666A1 (en) * | 1995-10-23 | 1997-05-01 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
DE19615710A1 (en) * | 1996-04-22 | 1997-10-23 | Forssmann Wolf Georg | Process for obtaining and using a biologically active protein - collagen fragment HF-COLL-18 / 514cf - in partially purified and synthetic form from body fluids to influence cell growth and the diagnosis of collagen diseases and osteoporosis |
WO1999048924A1 (en) * | 1998-03-24 | 1999-09-30 | The Children's Medical Center Corporation | Endostatin derived peptides with anti-angiogenic and anti-cancer activity |
WO2000063249A1 (en) * | 1999-04-15 | 2000-10-26 | Universita' Degli Studi Di Milano | Polypeptides derived from endostatin exhibiting antiangiogenic activity |
WO2000067771A1 (en) * | 1999-05-06 | 2000-11-16 | The Burnham Institute | Antiangiogenic endostatin peptides, endostatin variants and methods of use |
-
2001
- 2001-02-27 IT IT2001MI000394A patent/ITMI20010394A1/en unknown
-
2002
- 2002-02-27 JP JP2002567967A patent/JP2004534736A/en active Pending
- 2002-02-27 US US10/468,759 patent/US20040073007A1/en not_active Abandoned
- 2002-02-27 WO PCT/IT2002/000119 patent/WO2002068457A2/en not_active Application Discontinuation
- 2002-02-27 AU AU2002241253A patent/AU2002241253A1/en not_active Abandoned
- 2002-02-27 EP EP20020707102 patent/EP1370587A2/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015666A1 (en) * | 1995-10-23 | 1997-05-01 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
DE19615710A1 (en) * | 1996-04-22 | 1997-10-23 | Forssmann Wolf Georg | Process for obtaining and using a biologically active protein - collagen fragment HF-COLL-18 / 514cf - in partially purified and synthetic form from body fluids to influence cell growth and the diagnosis of collagen diseases and osteoporosis |
WO1999048924A1 (en) * | 1998-03-24 | 1999-09-30 | The Children's Medical Center Corporation | Endostatin derived peptides with anti-angiogenic and anti-cancer activity |
WO2000063249A1 (en) * | 1999-04-15 | 2000-10-26 | Universita' Degli Studi Di Milano | Polypeptides derived from endostatin exhibiting antiangiogenic activity |
WO2000067771A1 (en) * | 1999-05-06 | 2000-11-16 | The Burnham Institute | Antiangiogenic endostatin peptides, endostatin variants and methods of use |
Also Published As
Publication number | Publication date |
---|---|
JP2004534736A (en) | 2004-11-18 |
EP1370587A2 (en) | 2003-12-17 |
AU2002241253A1 (en) | 2002-09-12 |
WO2002068457A2 (en) | 2002-09-06 |
ITMI20010394A1 (en) | 2002-08-27 |
US20040073007A1 (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003290181A1 (en) | Radial artery compression system | |
WO2001034646A3 (en) | Recombinant gelatins | |
AU2003213246A1 (en) | Bone targeting peptides | |
AU2002357086A1 (en) | Healing abutment | |
AU2003298911A1 (en) | Cyclosporins for the treatment of autoimmune diseases | |
WO2003074546A8 (en) | Streptavidin-binding peptide | |
AU2003290563A1 (en) | Leptin-related peptides | |
AU4982200A (en) | Antiangiogenic endostatin peptides, endostatin variants and methods of use | |
WO2002068457A3 (en) | Antiangiogenic peptides derived from endostatin | |
AU2003228863A1 (en) | Immunogenic peptides | |
EP1499635B8 (en) | Teneurin c-terminal associated peptides (tcap) and uses thereof | |
AU2002335466A1 (en) | Gas insulated switch | |
PL368745A1 (en) | Peptides having antiangiogenic activity | |
AUPR160400A0 (en) | Plant virus promoter | |
EP1533374A4 (en) | Novel peptides having camp producing activity | |
AU2002250041A1 (en) | Putative human enzymes | |
AU2002241065A1 (en) | Heterocarpine, a human GHRH-binding protein | |
AU7618400A (en) | Human ubiquitin protease | |
AU2003261285A1 (en) | Tactile rhythm generator | |
AU2002233839A1 (en) | Peptide fragments, derived from human telomerase reverse transcriptase | |
AU2003254001A1 (en) | Novel htnfsf13b protein variants | |
WO2003031584A3 (en) | Axon repair | |
AU2002247836A1 (en) | Mycobacterrial estracts for treating autoimmune diseases | |
AU2002315383A1 (en) | Peptides having antiangiogenic activity | |
WO2002048326A8 (en) | Human caplain proteins and polynucleotides coding therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10468759 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002567967 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002707102 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002707102 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002707102 Country of ref document: EP |